Send me a link:

*Text messaging rates may apply.

 Dow Down0.03% Nasdaq Up0.28%

Northwest Biotherapeutics, Inc. (NWBO)

-NasdaqCM
6.60 Up 0.00(0.06%) 9:55AM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue -   -   400   272  
Cost of Revenue -   -   -   -  
Gross Profit -   -   400   272  
Operating Expenses
Research Development19,986  11,121  12,794  8,383  
Selling General and Administrative3,693  3,549  3,055  3,290  
Non Recurring -   -   -   -  
Others3  3  3  3  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (23,682) (14,673) (15,452) (11,404)
Income from Continuing Operations
Total Other Income/Expenses Net(22,237)(2,082)(7,392) -  
Earnings Before Interest And Taxes(45,919)(16,755)(22,844)(11,404)
Interest Expense122  136  66  190  
Income Before Tax(46,041)(16,891)(22,910)(11,594)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(46,041)(16,891)(22,910)(11,594)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (46,041) (16,891) (22,910) (11,594)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (46,041) (16,891) (22,910) (11,594)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.